PHASE 1 TRIAL INVESTIGATING THE SAFETY AND TOLERABILITY OF LEFLUNOMIDE IN PATIENTS WITH STEROIDDEPENDENT CHRONIC GRAFT-VERSUS-HOST DISEASE (CGVHD) AFTER ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANT (ALLOHCT)

Authors
Category Primary study
Conference50th Annual Meeting of the European Society for Blood and Marrow Transplantation
Year 2024
This article has no abstract
Epistemonikos ID: a4141d6f472728ce8d6de7f77d61a77b2abaa1a4
First added on: Feb 16, 2026